The United States Patent and Trademark Office’s (USPTO) Office of the Chief Economist released a report revealing that small companies and universities led the way in developing inventions to diagnose COVID-19, as evidenced by patent applications filed at the USPTO through April 2023.
The U.S. federal government helped spur this invention, with 10.7% of COVID-19 diagnostic public filings receiving support. The National Institutes of Health provided the most assistance (about 64%), while the National Science Foundation provided the second most, at 21.59%. Although COVID-19 diagnostic invention was highly concentrated in a few technologies, 8.6% of these inventions were also applicable to the treatment of COVID-19. Among 5,585 global COVID-19 diagnostic patent families found in this study, 47% have at least one filing at the China National Intellectual Property Administration (CNIPA), the most of any jurisdiction.
According to the latest WIPO World Intellectual Property Indicators 2025 report, global patenting activity reached…
The Presidium of the Russian Court for Intellectual Property Rights has upheld the decision of…
We are delighted to announce that our Managing Partner, Maria Nilova, will represent Patentica at…
The Intellectual Property Court of the Russian Federation has issued a definitive ruling in case…
Maria Nilova, Managing Partner of Patentica, will participate in two major international intellectual property congresses…
Effective August 8, 2025, Uzbekistan has enacted new legislation (No. 1080) that significantly toughens penalties…